Associated Papers
Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer.
Chiacchiarini M et al.
Pharmacology & Therapeutics, 2021
Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility.
Toledo RA et al.
Endocrine-related Cancer, 2015
25425582 (PubMed )
Supplement: supp_ERC-14-0491_Supplementary_table_2.xlsx › Sheet1
Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomas.
Dvorakova S et al.
Molecular and Cellular Endocrinology, 2008
Minireview: RET: normal and abnormal functions.
Santoro M et al.
Endocrinology, 2004
Dysfunction of the RET receptor in human cancer.
Santoro M et al.
Cellular and Molecular Life Sciences : Cmls, 2004
Select a paper to view details